Daniel K Spiegelman's Net Worth

$38.7 Million

Estimate Recalculated Nov 1, 2024 05:41AM EST

Who is Daniel K Spiegelman?

Daniel K Spiegelman has an estimated net worth of $38.7 Million. This is based on reported shares across multiple companies, which include Oncothyreon Inc., Relypsa Inc, BIOMARIN PHARMACEUTICAL INC, OMEROS CORP, MYRIAD GENETICS INC, XCYTE THERAPIES INC, SPRUCE BIOSCIENCES, INC., Jiya Acquisition Corp., AFFYMAX INC, Anthera Pharmaceuticals Inc, CV THERAPEUTICS INC, Kyverna Therapeutics, Inc., and vTv Therapeutics Inc..

SEC CIK

Daniel K Spiegelman's CIK is 0001238403

Past Insider Trading and Trends

2013 was Daniel K Spiegelman's most active year for acquiring shares with 18 total transactions. Daniel K Spiegelman's most active month to acquire stocks was the month of May. 2016 was Daniel K Spiegelman's most active year for disposing of shares, totalling 19 transactions. Daniel K Spiegelman's most active month to dispose stocks was the month of May. 2015 saw Daniel K Spiegelman paying a total of $4,023,129.30 for 196,048 shares, this is the most they've acquired in one year. In 2015 Daniel K Spiegelman cashed out on 208,287 shares for a total of $14,479,760.44, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Oncothyreon Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-21.01K
—
—
0
Mar 9
Form 4
+9.26%
1.78K
$3.94
-$2,340.36
21.01K
Sep 24
Form 4
+54.64%
6.79K
$3.78
-$8,561.70
19.23K
Jun 24
Form 4
+14.89%
1.61K
$3.34
-$1,793.58
12.43K
Jun 9 - Jun 12
Form 4
—
0
—
—
0
Jun 24
Form 4
—
0
—
—
0
Sep 24
Form 4
+29.60%
12.03K
$3.88
-$15,562.68
52.67K
Jun 12 - Jun 13
Form 4/A
+96.88%
20K
$1.61
$32,127.00
40.64K
Mar 25 - Mar 26
Form 4
+96.88%
20K
$1.61
$32,127.00
40.64K
Mar 25 - Mar 26
Form 4
-43.94%
-16.18K
$1.91
-$30,907.41
20.64K
Feb 20 - Jul 10
Form 4
-5.26%
-2.04K
$3.06
-$6,254.64
36.83K
Jun 6 - Jun 7
Form 4
+59.59%
14.51K
$3.65
-$17,658.70
38.87K
Mar 11
Form 4
—
0
—
—
0
Jun 13
Form 4
-4.45%
-1.14K
$1.86
-$2,111.10
24.36K
Jun 9
Form 4
+47.20%
8.17K
$3.67
$29,998.58
25.49K
Jun 7
Form 4
-10.45%
-2.02K
$3.51
-$7,093.71
17.32K
Jun 3
Form 4
-7.40%
-1.55K
$6.86
-$10,605.56
19.34K
Dec 4
Form 4
+46.35%
6.61K
—
—
20.89K
Jun 9 - Jun 12
Form 4
+130.74%
8.09K
—
—
14.27K
Jun 3
Form 4
∞
6.18K
—
—
6.18K
Dec 4
Form 4
—
0
—
—
0
Jun 12
Form 4/A
—
0
—
—
0
Mar 11
Form 4
—
0
—
—
0
Mar 11
Form 3
—
0
—
—
0
No matching records found

Relypsa Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-3.49K
$32.00
-$111,584.00
0
Sep 1
Form 4
+181.89%
2.25K
—
—
3.49K
Jun 21
Form 4
-45.02%
-1.01K
$19.31
-$19,561.64
1.24K
Jun 7
Form 4
∞
2.25K
—
—
2.25K
Jun 4
Form 4
—
0
—
—
0
Jun 19
Form 3
—
0
—
—
0
No matching records found

BIOMARIN PHARMACEUTICAL INC (BMRN) Snapshot price: $83.7

EVP, Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+0.37%
176
$68.78
$12,105.63
47.69K
Apr 30
Form 4
-22.09%
-13.47K
$89.00
-$1,199,097.00
47.51K
Scheduled
Apr 1
Form 4
-0.16%
-100.00
$90.00
-$9,000.00
60.98K
Scheduled
Mar 27
Form 4
-5.56%
-3.60K
$88.05
-$316,803.90
61.08K
Mar 22
Form 4
+3.43%
2.14K
$94.53
-$683,168.31
64.68K
Mar 15
Form 4
+22.04%
11.29K
$94.76
-$86,421.12
62.54K
Mar 1
Form 4
+0.34%
175
$68.78
$12,036.85
51.24K
Oct 31
Form 4
-16.37%
-10.00K
$99.00
-$990,004.72
51.07K
Scheduled
Jun 22
Form 4
-2.47%
-1.54K
$80.43
-$146,045.18
61.07K
Apr 30 - Jun 4
Form 4/A
-4.66%
-3.60K
$81.36
-$292,733.28
73.59K
Mar 22
Form 4/A
+21.90%
12.62K
—
—
70.22K
Feb 26
Form 4
-15.03%
-11.06K
$82.15
-$908,496.85
62.54K
Scheduled
Apr 23
Form 4
-4.64%
-3.58K
$81.36
-$291,512.88
73.6K
Mar 22
Form 4
+12.65%
8.66K
$83.57
-$318,819.55
77.19K
Mar 15
Form 4
-2.29%
-1.61K
$79.86
-$128,494.74
68.52K
Mar 2
Form 4
+21.75%
12.53K
—
—
70.13K
Feb 26
Form 4/A
—
0
$98.91
-$2,119,310.82
75.58K
Scheduled
May 27
Form 4
-7.17%
-1.80K
$90.72
-$163,386.72
23.3K
Jun 2
Form 4
-5.88%
-1.57K
$80.90
-$146,665.88
25.1K
Apr 28 - May 15
Form 4
+84.31%
12.2K
—
—
26.67K
Mar 22
Form 4
-30.30%
-6.29K
$92.33
-$580,750.94
14.47K
Scheduled
Mar 15 - Mar 16
Form 4
-9.99%
-2.30K
$93.32
-$214,915.96
20.76K
Scheduled
Mar 6
Form 4
-9.01%
-2.28K
$93.95
-$214,487.85
23.06K
Mar 3
Form 4
-16.48%
-5.00K
$78.58
-$1,399,500.00
25.35K
Scheduled
Feb 28 - Mar 1
Form 4
+67.66%
12.25K
—
—
30.35K
Feb 24
Form 4
-21.65%
-5.00K
$90.00
-$450,000.00
18.1K
Scheduled
Jan 9
Form 4
-46.21%
-19.84K
$79.53
-$1,801,529.05
23.1K
Oct 31 - Nov 9
Form 4
-8.52%
-4.00K
$99.33
-$397,320.00
42.94K
Scheduled
Aug 1
Form 4
-3.39%
-1.65K
$89.14
-$146,991.86
46.94K
Scheduled
Jun 6
Form 4/A
—
0
—
—
0
May 31
Form 4
-3.57%
-1.80K
$90.00
-$162,090.00
48.59K
Jun 3
Form 4
-7.26%
-3.94K
$64.47
-$1,213,167.99
50.39K
Scheduled
May 31
Form 4
-7.34%
-4.30K
$89.09
-$383,532.45
54.34K
May 27
Form 4
-6.04%
-3.77K
$87.07
-$328,184.17
58.64K
Scheduled
May 23
Form 4
-2.38%
-1.52K
$66.99
-$132,071.29
62.41K
Apr 29 - May 13
Form 4
+35.18%
16.64K
—
—
63.93K
Mar 15
Form 4
-4.82%
-2.40K
$89.57
-$214,520.15
47.29K
Mar 3
Form 4
-50.84%
-51.39K
$82.25
-$4,226,852.24
49.69K
Scheduled
Feb 29 - Mar 2
Form 4
+255.35%
72.63K
—
—
101.08K
Feb 24
Form 4
—
0
$71.68
-$1,304,718.00
28.23K
Scheduled
Nov 16
Form 4
-10.89%
-3.45K
$121.34
-$418,617.53
28.23K
Scheduled
Jun 4 - Jun 5
Form 4
-23.68%
-9.83K
$125.10
-$1,229,455.07
31.68K
Scheduled
May 29 - Jun 1
Form 4
-45.09%
-34.08K
$130.00
-$4,430,140.00
41.51K
Scheduled
May 18
Form 4
+0.54%
425
$122.27
$49,988.96
75.58K
Scheduled
Apr 30 - May 18
Form 4
+15.27%
10.5K
—
—
79.28K
Mar 3
Form 4
—
0
$73.03
-$1,053,070.00
68.68K
Mar 2
Form 4
+0.08%
57
$67.63
$3,441.41
68.73K
Mar 18 - Sep 3
Form 4
—
0
$54.45
-$492,353.60
68.68K
Sep 2
Form 4
-3.14%
-2.23K
$61.76
-$137,651.90
68.68K
Aug 1
Form 4
-3.05%
-2.23K
$64.00
-$142,656.00
70.91K
Jul 2
Form 4
+23.26%
13.8K
—
—
73.13K
Jun 4
Form 4
-6.01%
-3.79K
$57.50
-$218,040.00
59.33K
May 29
Form 4
-1.78%
-1.15K
$53.47
-$66,630.46
63.13K
Apr 30 - May 15
Form 4
—
0
$59.69
-$330,050.40
64.27K
Scheduled
Mar 3
Form 4
+69.04%
26.25K
—
—
64.27K
Feb 14
Form 4
—
0
$54.60
-$279,732.60
37.95K
Scheduled
Dec 2
Form 4
—
0
$54.03
-$269,460.00
37.95K
Scheduled
Sep 4
Form 4
-9.68%
-4.07K
$59.78
-$243,063.04
37.95K
Scheduled
Jul 1
Form 4
-9.06%
-4.18K
$64.46
-$269,700.64
42.02K
May 29
Form 4
+40.00%
13.2K
—
—
46.2K
May 15
Form 4
—
0
$51.74
-$710,217.20
33K
May 1
Form 4
∞
33K
—
—
33K
May 29
Form 3
—
0
—
—
0
No matching records found

OMEROS CORP (OMER) Snapshot price: $3.71

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
May 27
Form 4
—
0
—
—
0
Dec 8
Form 3
—
0
—
—
0
No matching records found

MYRIAD GENETICS INC (MYGN) Snapshot price: $26.97

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Form 4
-18.71%
-7.58K
$22.05
-$167,012.92
32.92K
Scheduled
Jun 3 - Jun 4
Form 4
+19.17%
6.51K
$23.01
-$198,760.38
40.49K
Jun 1 - Jun 2
Form 4
-15.90%
-6.42K
$19.25
-$123,672.92
33.98K
Scheduled
Jun 6
Form 4
+74.69%
17.27K
—
—
40.4K
Jun 2
Form 4
-11.95%
-3.14K
$30.52
-$95,794.75
23.13K
Scheduled
Jun 17
Form 4
+95.74%
12.85K
—
—
26.27K
Jun 3
Form 4
-34.73%
-7.14K
$28.99
-$207,023.01
13.42K
Scheduled
May 28
Form 4
-43.59%
-15.89K
—
—
20.56K
May 27
Form 4
+77.27%
15.89K
—
—
36.45K
Dec 4
Form 4
∞
20.56K
—
—
20.56K
May 27
Form 3
—
0
—
—
0
No matching records found